Association of lipopolysaccharide-binding protein with aging-related adiposity change and prediabetes among African ancestry men

Diabetes Care

Volumn 39, Issue 3, 2016, Pages 385-391

  Tilves, Curtis M ^a   Zmuda, Joseph M ^a   Kuipers, Allison L ^a   Nestlerode, Cara S ^a   Evans, Rhobert W ^a   Bunker, Clareann H ^a   Patrick, Alan L ^b   Miljkovic, Iva ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b Tobago Health Studies Office   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE BINDING PROTEIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CARRIER PROTEIN; GLUCOSE BLOOD LEVEL; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ADULT; AGING; ARTICLE; BLACK PERSON; BODY HEIGHT; BODY MASS; BODY WEIGHT; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; MALE; METABOLIC PARAMETERS; MUSCULOSKELETAL SYSTEM PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE; AGED; ANALYSIS; BLOOD; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE-PHASE PROTEINS; ADIPOSITY; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGING; BIOMARKERS; BLOOD GLUCOSE; CARRIER PROTEINS; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OBESITY; PREDIABETIC STATE; PROSPECTIVE STUDIES;

EID: 84962074365     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1777     Document Type: Article

References (40)

1. Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitusand inflammation. Curr Diab Rep 2013;13:435-444
2. Manco M, Putignani L, Bottazzo GF. Gut mi-crobiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010;31:817-844
3. Kelly CJ, Colgan SP, Frank DN. Of microbes and meals: the health consequences of dietary endotoxemia. Nutr Clin Pract 2012;27:215-225
4. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635-700
5. Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003;16:379-414
6. Grube BJ, Cochane CG, Ye RD, et al. Lipo-polysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem 1994;269:8477-8482
7. Ding PH, Jin LJ. The role of lipopolysaccha-ride-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health. J Periodontal Res 2014;49:1-9
8. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994;180:1025-1035
9. Lamping N, Dettmer R, Schröder NW, et al. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 1998;101:2065-2071
10. Novitsky TJ. Limitations of the Limulus ame-bocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci 1998;851: 416-421
11. Moreno-Navarrete JM, Ortega F, Serino M, et al. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes 2012;36:1442-1449
12. Moreno-Navarrete JM, Escoté X, Ortega F, et al. A role for adipocyte-derived lipopolysac-charide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 2013;56:2524-2537
13. Liu X, Lu L, Yao P, et al. Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese. Diabe-tologia 2014;57:1834-1841
14. Ruiz AG, Casafont F, Crespo J, et al. Lipo-polysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of en-dotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 2007;17:1374-1380
15. Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F. Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 2013;8:e54600
16. Serrano M, Moreno-Navarrete JM, Puig J, et al. Serum lipopolysaccharide-binding protein as a marker of atherosclerosis. Atherosclerosis 2013;230:223-227
17. Kheirandish-Gozal L, Peris E, Wang Y, et al. Lipopolysaccharide-binding protein plasma levels in children: effects of obstructive sleep apnea and obesity. J Clin Endocrinol Metab 2014; 99:656-663
18. Sun L, Yu Z, Ye X, et al. A marker of endo-toxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 2010;33:1925-1932
19. Hennis A, Wu SY, Nemesure B, Li X, Leske MC; Barbados Eye Study Group. Diabetes in a Caribbean population: epidemiological profile and implications. Int J Epidemiol 2002;31:234-239
20. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000;283:2253-2259
21. Bunker CH, Patrick AL, KonetyBR, et al. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev 2002;11:726-729
22. Simonsick EM, Maffeo CE, Rogers SK, et al. Methodology and feasibility of a home-based examination in disabled older women: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 1997;52:M264-M274
23. Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) 2000;89:104-110
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
25. Bonora E, Targher G, Alberiche M, et al. Ho-meostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63
26. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-246
27. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011;29:415-445
28. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-1772
29. Blairon L, Wittebole X, Laterre PF. Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J Infect Dis 2003;187:287-291
30. van Greevenbroek MM, Schalkwijk CG, Stehouwer CD. Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med 2013;71:174-187
31. Doyle A, Zhang G, Abdel Fattah EA, Eissa NT, Li YP. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinateactivationofubiquitin-proteasome and autophagy-lysosome pathways. FASEB J 2011;25:99-110
32. Miljkovic I, Cauley JA, Petit MA, et al.; Os-teoporotic Fractures in Men Research Group; Tobago Health Studies Research Group. Greater adipose tissue infiltration in skeletal muscle among older men of African ancestry. J Clin En-docrinol Metab 2009;94:2735-2742
33. Albu JB, Kovera AJ, Allen L, et al. Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. Am J Clin Nutr 2005;82:1210-1217
34. Gallagher D, Kuznia P, Heshka S, et al. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 2005;81:903-910
35. Visser M, Kritchevsky SB, Goodpaster BH, et al. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study. J Am Geriatr Soc 2002; 50:897-904
36. Ryan AS, Nicklas BJ, Berman DM. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women. Obes Res 2002;10:336-344
37. Goodpaster BH, Krishnaswami S, Resnick H, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003;26:372-379
38. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 2000;71:885-892
39. Reyna SM, Ghosh S, Tantiwong P, et al. Elevated Toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 2008;57:2595-2602
40. Zhou H, Hu J, Zhu Q, et al. Lipopolysaccharide-binding protein cannot independently predict type 2 diabetes mellitus: a nested case-control study. J Diabetes 6 Mar 2015 [Epub ahead of print]. DOI: 10.1111/1753-0407.12281